India Today CENTER (0.0) Reliability: 7.0/10

Exclusive: Inside factory of Coldrif cough syrup that killed several children

📅 October 08, 2025 12:00 AM 🕐 Scraped: October 08, 2025

Summary: This India Today exclusive investigates the Kanchipuram-based Srisan Pharmaceuticals, manufacturer of the ‘cold rift’ cough syrup linked to the deaths of 16 children in India. The report reveals over 350 violations at the plant, from unhygienic conditions and rusted equipment to improper waste disposal. A key finding was the presence of diethylene glycol, a toxic industrial solvent, in the syrup, indicating illegal procurement and gross negligence. The investigation questions the motive for using the lethal chemical over a safer alternative: “Was it keeping a financial interest in mind? Or was there some other, you know, skeletons that are yet to tumble out of the closet?” Following the exposé, the plant is sealed, a show-cause notice has been issued, and police have formed an SIT and are searching for the absconding owner, Ranganathan Govindarajan.

This India Today exclusive investigates the Kanchipuram-based Srisan Pharmaceuticals, manufacturer of the ‘cold rift’ cough syrup

📰

Continue Reading on India Today

This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.

Read Full Article →

How do you feel about this article?

Read Original Article →

📝 Article Information

Author

Not specified

Original Publisher

🌍 India Today

CENTER Bias (0.0)

Published Date

October 08, 2025 at 12:00 AM

ℹ️

Disclaimer

ArkforgeAI.com - Newsource is a news aggregation platform. We do not create, write, or produce original news content. All articles are sourced from their respective publishers and remain the property of their original creators. We analyze and aggregate news from multiple sources to provide diverse perspectives across the political spectrum.

The content displayed here is for informational purposes only. For the complete and original article, please visit the source's website using the "Read Original Article" link above.

Desktop Only